Form 8-K - Current report:
SEC Accession No. 0001628280-21-009179
Filing Date
2021-05-06
Accepted
2021-05-06 08:16:10
Documents
17
Period of Report
2021-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20210506.htm   iXBRL 8-K 36428
2 EX-99.1 ardx-20210331xexhibit991.htm EX-99.1 58197
8 ardx-20210506_g1.jpg GRAPHIC 2570
9 image_01.jpg GRAPHIC 2381
  Complete submission text file 0001628280-21-009179.txt   291375

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20210506.xsd EX-101.SCH 2420
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20210506_cal.xml EX-101.CAL 708
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20210506_def.xml EX-101.DEF 15486
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20210506_lab.xml EX-101.LAB 29894
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20210506_pre.xml EX-101.PRE 16143
10 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20210506_htm.xml XML 13683
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 21895905
SIC: 2834 Pharmaceutical Preparations